tenofovir and amg531
tenofovir has been researched along with amg531 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Ahmed, KN; Hafeez, M; Khan, RG; Rafe, A; Rasool, G; Sarfraz, T | 1 |
Other Studies
3 other study(ies) available for tenofovir and amg531
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Hepatitis B Leading to Megaloblastic Anemia and Catastrophic Peripheral Thrombocytopenia.
Topics: Adult; Anemia, Megaloblastic; Benzoates; Folic Acid; Folic Acid Deficiency; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Hydrazines; Male; Platelet Count; Polymerase Chain Reaction; Pyrazoles; Tenofovir; Thrombocytopenia; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B Complex | 2016 |